Virulizin immunotherapeutic: IMUTF will begin a Phase I/II Canadian trial with Virulizin in about HIV patients

The company suspended its trial program in October 1994, after it was found that the potency assay used to measure the drug's biological activity could produce inaccurate results. The new assay was co...